Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/19/25 16:08 | 12/17/25 | GALT | Health | Drug | Pharmaceutical Preparations | Lewis Joel | GA | DO | P,CEO | 7 | S.dm | -438 | 3.71 | 0 | -118 | 899 | D | |||||||||||||||
12/19/25 16:06 | 12/17/25 | GALT | Health | Drug | Pharmaceutical Preparations | Jamil Khurram | GA | O | Chief Me | 3 | S.d | -811 | 5.26 | 0 | -154 | 26 | D | |||||||||||||||
12/19/25 16:05 | 12/17/25 | GALT | Health | Drug | Pharmaceutical Preparations | Shlevin Harold H. | GA | D | 3 | S.dm | -1,405 | 6.15 | 0 | -228 | 31 | D | ||||||||||||||||
12/18/25 10:34 | 12/16/25 | GALT | Health | Drug | Pharmaceutical Preparations | 10X Fund, L.P. | GA | T | 5 | S.m | -2,434 | 5.62 | 0 | -433 | 5,872 | D | ||||||||||||||||
11/19/25 16:01 | 11/17/25 | GALT | Health | Drug | Pharmaceutical Preparations | Callicutt Jack W | GA | O | CFO | 6 | S.dm | -803 | 4.87 | 0 | -165 | 15 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |